Search

for
Search:

GlossarySorafenib

medication that inhibits proteins to slow cancer growth

Sorafenib is a medication primarily used to treat certain types of cancer, such as liver, kidney, and thyroid cancers. It works by inhibiting multiple proteins involved in tumor cell growth and angiogenesis (the formation of new blood vessels that supply the tumor), thereby slowing the progression of the disease.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 167 results

research Sorafenib-Associated Facial Acneiform Eruption

15 citations , December 2014 in “Dermatology and therapy”

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

research Sorafenib-Induced Eruption Resembling Pityriasis Rubra Pilaris

21 citations , July 2011 in “Journal of the American Academy of Dermatology”

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

research Unusual Progression of Renal Cell Carcinoma with Carcinomatosis Peritoneii and Krukenberg Tumor and Alopecia with Sunitinib Therapy in a Young Female

4 citations , February 2018 in “World journal of surgical oncology”

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

research Case of Alopecia Induced by Sorafenib, Possible Mechanism Similar to Alopecia Areata

4 citations , November 2017 in “The Journal of Dermatology”

Sorafenib may cause hair loss in a way similar to alopecia areata.

research Adverse Hair Reactions to New Targeted Therapies for Cancer

1 citations , March 2019 in “Actas Dermo-Sifiliográficas”

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

View more "sorafenib" in research →

Community Join

0 / 0 results

— no results